Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junjiang Liu

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Biomed Research International|September 9, 2020
Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate CancerShoubin Li, Chunhong Yu, Yunxia Zhang, et al.
Annals of Medicine|March 16, 2026
Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trialJiaping Xu, Hao Peng, Yafang Zhu, et al.
Nature|March 1, 2023
Disorder-tuned conductivity in amorphous monolayer carbonHuifeng Tian, Yinhang Ma, Zhenjiang Li, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Biomed Research International|September 9, 2020
Circular RNA cir-ITCH Is a Potential Therapeutic Target for the Treatment of Castration-Resistant Prostate CancerShoubin Li, Chunhong Yu, Yunxia Zhang, et al.
Annals of Medicine|March 16, 2026
Tirofiban with sequential dual antiplatelet therapy in mild acute ischemic stroke (TiMIS): protocol for a multicenter, randomized controlled trialJiaping Xu, Hao Peng, Yafang Zhu, et al.
Nature|March 1, 2023
Disorder-tuned conductivity in amorphous monolayer carbonHuifeng Tian, Yinhang Ma, Zhenjiang Li, et al.
Pageof 7